Sanders, Novo Nordisk CEO clash over Ozempic, Wegovy drug prices
The CEO of Novo Nordisk did not commit to lowering the prices of Ozempic and Wegovi during a Senate hearing on Tuesday, despite repeated pressure from Sen. Bernie Sanders (I-VT), chairman of the Senate Health, Education, Labor and Pensions Committee. Novo Nordisk CEO Lars Fruagaard Jorgensen told senators on Tuesday that pharmacy benefit managers (PBMs), […]